19 related articles for article (PubMed ID: 34622842)
1. Clinical and microbiological characteristics of female patients with acute pyelonephritis who experienced urinary tract infections within the previous year.
Yoon C; Kim J; Jang W; Ko JW; Kim J; Pai H; Lee Y; Kim B
J Infect Public Health; 2024 Feb; 17(2):349-358. PubMed ID: 38198967
[TBL] [Abstract][Full Text] [Related]
2. Toward an optimization of empirical antibiotic therapy in acute graft pyelonephritis: A retrospective multicenter study.
Martinet P; Lanfranco L; Coste A; Tandé D; Danneels P; Picard L; Danthu C; Jamard S; Gaborit B; Faucher JF; Talarmin JP; Le Meur Y; An Nguyen T; Masset C; Kerleau C; Ansart S; Rezig S;
Infect Dis Now; 2024 May; 54(5):104922. PubMed ID: 38754702
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the Optimum Preparation of Peach Gum Polysaccharides and the In Vivo and In Vitro Therapeutic Effects on Acute Pyelonephritis.
Zhang F; Bai J; Zheng Y; Liang S; Lei L; Deng X; Li W; Liu P; Yang G; Ren Y
Evid Based Complement Alternat Med; 2019; 2019():2729343. PubMed ID: 31911807
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of healthcare-associated infection in patients with community-onset acute pyelonephritis.
Ha YE; Kang CI; Joo EJ; Park SY; Kang SJ; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
Scand J Infect Dis; 2011 Aug; 43(8):587-95. PubMed ID: 21453206
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
Etienne M; Van Elslande H; Choplin-Renard J; Pestel-Caron M; Caron F
Med Mal Infect; 2014 May; 44(5):217-22. PubMed ID: 24787633
[TBL] [Abstract][Full Text] [Related]
6. Role of piperacillin/tazobactam as a carbapenem-sparing antibiotic for treatment of acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli.
Yoon YK; Kim JH; Sohn JW; Yang KS; Kim MJ
Int J Antimicrob Agents; 2017 Apr; 49(4):410-415. PubMed ID: 28263710
[TBL] [Abstract][Full Text] [Related]
7. A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis.
Bosch-Nicolau P; Falcó V; Viñado B; Andreu A; Len O; Almirante B; Pigrau C
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971876
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the clinical characteristics of elderly and non-elderly women with community-onset, non-obstructive acute pyelonephritis.
Chang UI; Kim HW; Noh YS; Wie SH
Korean J Intern Med; 2015 May; 30(3):372-83. PubMed ID: 25995668
[TBL] [Abstract][Full Text] [Related]
9. Clinical and microbiological characteristics of men with nonobstructive acute pyelonephritis: A multicenter retrospective observational study.
Park MG; Cho SY; Kwon SY; Choi H; Lee JW
Medicine (Baltimore); 2021 Oct; 100(40):e27386. PubMed ID: 34622842
[TBL] [Abstract][Full Text] [Related]
10. Community-acquired, healthcare-associated and hospital-acquired bloodstream infection definitions in children: a systematic review demonstrating inconsistent criteria.
Henderson KL; Müller-Pebody B; Johnson AP; Wade A; Sharland M; Gilbert R
J Hosp Infect; 2013 Oct; 85(2):94-105. PubMed ID: 24011498
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
